- Home
- ICLR vs WST Comparison
ICLR vs WST Comparison
Compare ICLR & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- WST
- Stock Information
- Founded
- ICLR 1990
- WST 1923
- Country
- ICLR Ireland
- WST United States
- Employees
- ICLR 41100
- WST N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- WST Medical/Dental Instruments
- Sector
- ICLR Health Care
- WST Health Care
- Exchange
- ICLR Nasdaq
- WST Nasdaq
- Market Cap
- ICLR 24.3B
- WST 22.1B
- IPO Year
- ICLR 1998
- WST N/A
- Fundamental
- Price
- ICLR $293.54
- WST $296.41
- Analyst Decision
- ICLR Strong Buy
- WST Buy
- Analyst Count
- ICLR 10
- WST 4
- Target Price
- ICLR $351.60
- WST $442.75
- AVG Volume (30 Days)
- ICLR 824.8K
- WST 399.2K
- Earning Date
- ICLR 10-23-2024
- WST 10-24-2024
- Dividend Yield
- ICLR N/A
- WST 0.27%
- EPS Growth
- ICLR 39.27
- WST 2.48
- EPS
- ICLR 8.61
- WST 7.04
- Revenue
- ICLR $8,331,892,000.00
- WST $2,876,900,000.00
- Revenue This Year
- ICLR $6.84
- WST N/A
- Revenue Next Year
- ICLR $8.10
- WST $6.96
- P/E Ratio
- ICLR $34.07
- WST $42.25
- Revenue Growth
- ICLR 5.42
- WST 0.38
- 52 Week Low
- ICLR $221.20
- WST $265.00
- 52 Week High
- ICLR $347.72
- WST $413.70
- Technical
- Relative Strength Index (RSI)
- ICLR 45.56
- WST 47.70
- Support Level
- ICLR $280.96
- WST $295.06
- Resistance Level
- ICLR $305.14
- WST $303.30
- Average True Range (ATR)
- ICLR 8.88
- WST 7.26
- MACD
- ICLR 0.83
- WST -0.72
- Stochastic Oscillator
- ICLR 42.53
- WST 29.04
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.